Cholinergic systems: human diseases, animal models, and prospects for therapy.
Price
D L
DL
Department of Pathology and Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Koliatsos
V E
VE
Clatterbuck
R C
RC
D000109:Acetylcholine / Q000502:physiology*; D000544:Alzheimer Disease / Q000503:physiopathology; D000690:Amyotrophic Lateral Sclerosis / Q000503:physiopathology; D000818:Animals; D001931:Brain Mapping; D002799:Cholinergic Fibers / Q000502:physiology* / Q000648:ultrastructure; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008818:Mice, Neurologic Mutants; D009414:Nerve Growth Factors / Q000502:physiology; D009422:Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology*; D009434:Neural Pathways / Q000502:physiology / Q000648:ultrastructure; D009474:Neurons / Q000737:chemistry / Q000502:physiology; D016548:Prosencephalon / Q000502:physiology; D017475:Receptors, Nerve Growth Factor / Q000502:physiology; D013116:Spinal Cord / Q000502:physiology; D013132:Spinocerebellar Degenerations / Q000503:physiopathology
D009414:Nerve Growth Factors; D017475:Receptors, Nerve Growth Factor; D000109:Acetylcholine